(USD) | Mar 2024 | Q/Q |
---|---|---|
Revenue | 57.3B | +12% |
Gross Profit | 15.8B | - |
Cost Of Revenue | 41.4B | +17% |
Operating Income | 2.3B | +10% |
Operating Expenses | 13.6B | - |
Net Income | -212MM | -119% |
G&A | 3.7B | -9% |
Amortization | 423MM | -6% |
Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from
FinraMoving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.
Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.
UnitedHealth, The Cigna and Centene are part of the Zacks Industry Outlook article.
Here is how Cigna (CI) and atai Life Sciences N.V. (ATAI) have performed compared to their sector so far this year.
Molina Healthcare (MOH) continues to expect premium revenues at around $38 billion for the full year.
Cigna (CI) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Rising premiums, technological advancements and increased demand for Medicare plans are expected to drive the performances of the Zacks Medical-HMO industry players. UNH, CI and CNC are poised to benefit from encouraging industry prospects.
The Board of Directors of The Cigna Group (NYSE: CI) today declared a cash dividend of $1.40 per share of its common stock, payable on September 19, 2024 to shareholders of record as of the close of business on September 4, 2024.
Top executives of CVS Caremark, Optum Rx and Express Scripts made a rare congressional appearance to defend pharmacy benefit managers’ drug pricing policies.
Findings from the House Oversight investigation add to criticism that pharmacy-benefit managers are driving up drug spending.
Update: Market Chatter: House Probe Finds Middlemen Push Patients to Pricier Drugs
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.